Compare $BIXT vs $MTNB | Chartloom

Compare

$BIXT vs $MTNB

Bioxytran Inc · Matinas BioPharma Holdings Inc

BIXT

Bioxytran Inc

MTNB

Matinas BioPharma Holdings Inc

Compare $BIXT vs $MTNB

Comparing Bioxytran Inc and Matinas BioPharma Holdings Inc

BIXTBioxytran Inc

MTNBMatinas BioPharma Holdings Inc

BIXTBioxytran Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-68.2%

52W performance

-67.7%

FCF yield

-34.2%

MTNBMatinas BioPharma Holdings Inc

Market cap

$39M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-69.1%

52W performance

-89.8%

FCF yield

-16.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BIXT

MTNB

Detailed metrics comparison

BIXT

Bioxytran Inc

MTNB

Matinas BioPharma Holdings Inc

Market Cap

BIXT$3M

MTNB$39M

Enterprise Value

BIXT$4M

MTNB$39M

Price

BIXT$0.02

MTNB$2.87

P/E Ratio

BIXTN/A

MTNBN/A

P/S Ratio

BIXT18.76x

MTNB0.60x

EV/Sales

BIXT19.26x

MTNB0.43x

EV/EBITDA

BIXT121.99x

MTNB0.00x

P/B Ratio

BIXT4.86x

MTNB1.44x

P/FCF Ratio

BIXTN/A

MTNBN/A

EV/FCF

BIXT-4.08x

MTNB-6.00x

PEG Ratio

BIXTN/A

MTNBN/A

Forward P/E (NTM)

BIXTN/A

MTNBN/A

Forward P/S (NTM)

BIXTN/A

MTNBN/A

Revenue (TTM)

BIXT$0

MTNB$0

Revenue Growth (YoY)

BIXTN/A

MTNBN/A

Forward Rev Growth

BIXT0.0%

MTNB0.0%

Gross Margin (TTM)

BIXT47.4%

MTNB0.0%

Operating Margin (TTM)

BIXT0.0%

MTNB0.0%

EBITDA Margin (TTM)

BIXT0.0%

MTNB0.0%

Net Margin (TTM)

BIXT0.0%

MTNB0.0%

FCF Margin (TTM)

BIXTN/A

MTNBN/A

Net Income (TTM)

BIXT$-3M

MTNB$-3M

FCF (TTM)

BIXT$-893K

MTNB$-6M

EPS (TTM)

BIXT-$0.03

MTNB$0.00

ROE (TTM)

BIXT-755.0%

MTNB-13745.0%

ROA (TTM)

BIXT-79248.0%

MTNB-9202.0%

ROIC (TTM)

BIXT-612.0%

MTNB-13717.0%

Cash

BIXT$177K

MTNB$761K

Debt

BIXT$1M

MTNB$6K

Net Cash/Debt

BIXT$-1M

MTNB$755K

Current Ratio (TTM)

BIXT0.03x

MTNB0.85x

Quick Ratio (TTM)

BIXT0.03x

MTNB0.60x

Debt/Equity (TTM)

BIXT0.20x

MTNB0.00x

Debt/Assets (TTM)

BIXT0.0%

MTNB0.0%

Interest Coverage (TTM)

BIXTN/A

MTNBN/A

Net Debt/EBITDA (TTM)

BIXT0.00x

MTNB0.00x

Beta

BIXT2.80

MTNB2.20

52W Performance

BIXT-67.7%

MTNB-89.8%

YTD Performance

BIXT-68.2%

MTNB-69.1%

% from 52W High

BIXT-75.9%

MTNB-90.1%

% from 52W Low

BIXT14.5%

MTNB27.1%

Asset Turnover (TTM)

BIXT0.50x

MTNB0.09x

FCF Yield (TTM)

BIXT-34.2%

MTNB-16.3%

Earnings Yield (TTM)

BIXT-133.6%

MTNB-8.8%

Dividend Yield (TTM)

BIXTN/A

MTNBN/A

Rule of 40

BIXT0.0

MTNB0.0

EV/GP/RG

BIXTN/A

MTNBN/A

Ticker research

View BIXT research View MTNB research

Metric	BIXT Bioxytran Inc	MTNB Matinas BioPharma Holdings Inc
Market & Valuation
Market Cap	$3M	$39M
Enterprise Value	$4M	$39M
Price	$0.02	$2.87
P/E Ratio	N/A	N/A
P/S Ratio	18.76x	0.60x
EV/Sales	19.26x	0.43x
EV/EBITDA	121.99x	0.00x
P/B Ratio	4.86x	1.44x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.08x	-6.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	47.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-3M	$-3M
FCF (TTM)	$-893K	$-6M
EPS (TTM)	-$0.03	$0.00
ROE (TTM)	-755.0%	-13745.0%
ROA (TTM)	-79248.0%	-9202.0%
ROIC (TTM)	-612.0%	-13717.0%
Financial Health
Cash	$177K	$761K
Debt	$1M	$6K
Net Cash/Debt	$-1M	$755K
Current Ratio (TTM)	0.03x	0.85x
Quick Ratio (TTM)	0.03x	0.60x
Debt/Equity (TTM)	0.20x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.80	2.20
52W Performance	-67.7%	-89.8%
YTD Performance	-68.2%	-69.1%
% from 52W High	-75.9%	-90.1%
% from 52W Low	14.5%	27.1%
Efficiency & Yields
Asset Turnover (TTM)	0.50x	0.09x
FCF Yield (TTM)	-34.2%	-16.3%
Earnings Yield (TTM)	-133.6%	-8.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BIXT research	View MTNB research

Valuation

P/S Ratio

MTNB

0.60x

BIXT

18.76x

EV/FCF

MTNB

-6.00x

BIXT

-4.08x

Growth & revenue

Forward Revenue Growth

BIXT

0.0%

MTNB

0.0%

Profitability & performance

Gross Margin

BIXT

47.4%

MTNB

0.0%

ROE

BIXT

-755.0%

MTNB

-13745.0%

FCF Yield %

MTNB

-16.3%

BIXT

-34.2%

52-Week Performance

BIXT

-67.7%

MTNB

-89.8%

Detailed metrics comparison

BIXT

Bioxytran Inc

MTNB

Matinas BioPharma Holdings Inc

Market Cap

BIXT$3M

MTNB$39M

Enterprise Value

BIXT$4M

MTNB$39M

Price

BIXT$0.02

MTNB$2.87

P/E Ratio

BIXTN/A

MTNBN/A

P/S Ratio

BIXT18.76x

MTNB0.60x

EV/Sales

BIXT19.26x

MTNB0.43x

EV/EBITDA

BIXT121.99x

MTNB0.00x

P/B Ratio

BIXT4.86x

MTNB1.44x

P/FCF Ratio

BIXTN/A

MTNBN/A

EV/FCF

BIXT-4.08x

MTNB-6.00x

PEG Ratio

BIXTN/A

MTNBN/A

Forward P/E (NTM)

BIXTN/A

MTNBN/A

Forward P/S (NTM)

BIXTN/A

MTNBN/A

Revenue (TTM)

BIXT$0

MTNB$0

Revenue Growth (YoY)

BIXTN/A

MTNBN/A

Forward Rev Growth

BIXT0.0%

MTNB0.0%

Gross Margin (TTM)

BIXT47.4%

MTNB0.0%

Operating Margin (TTM)

BIXT0.0%

MTNB0.0%

EBITDA Margin (TTM)

BIXT0.0%

MTNB0.0%

Net Margin (TTM)

BIXT0.0%

MTNB0.0%

FCF Margin (TTM)

BIXTN/A

MTNBN/A

Net Income (TTM)

BIXT$-3M

MTNB$-3M

FCF (TTM)

BIXT$-893K

MTNB$-6M

EPS (TTM)

BIXT-$0.03

MTNB$0.00

ROE (TTM)

BIXT-755.0%

MTNB-13745.0%

ROA (TTM)

BIXT-79248.0%

MTNB-9202.0%

ROIC (TTM)

BIXT-612.0%

MTNB-13717.0%

Cash

BIXT$177K

MTNB$761K

Debt

BIXT$1M

MTNB$6K

Net Cash/Debt

BIXT$-1M

MTNB$755K

Current Ratio (TTM)

BIXT0.03x

MTNB0.85x

Quick Ratio (TTM)

BIXT0.03x

MTNB0.60x

Debt/Equity (TTM)

BIXT0.20x

MTNB0.00x

Debt/Assets (TTM)

BIXT0.0%

MTNB0.0%

Interest Coverage (TTM)

BIXTN/A

MTNBN/A

Net Debt/EBITDA (TTM)

BIXT0.00x

MTNB0.00x

Beta

BIXT2.80

MTNB2.20

52W Performance

BIXT-67.7%

MTNB-89.8%

YTD Performance

BIXT-68.2%

MTNB-69.1%

% from 52W High

BIXT-75.9%

MTNB-90.1%

% from 52W Low

BIXT14.5%

MTNB27.1%

Asset Turnover (TTM)

BIXT0.50x

MTNB0.09x

FCF Yield (TTM)

BIXT-34.2%

MTNB-16.3%

Earnings Yield (TTM)

BIXT-133.6%

MTNB-8.8%

Dividend Yield (TTM)

BIXTN/A

MTNBN/A

Rule of 40

BIXT0.0

MTNB0.0

EV/GP/RG

BIXTN/A

MTNBN/A

Ticker research

View BIXT research View MTNB research

Metric	BIXT Bioxytran Inc	MTNB Matinas BioPharma Holdings Inc
Market & Valuation
Market Cap	$3M	$39M
Enterprise Value	$4M	$39M
Price	$0.02	$2.87
P/E Ratio	N/A	N/A
P/S Ratio	18.76x	0.60x
EV/Sales	19.26x	0.43x
EV/EBITDA	121.99x	0.00x
P/B Ratio	4.86x	1.44x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.08x	-6.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	47.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-3M	$-3M
FCF (TTM)	$-893K	$-6M
EPS (TTM)	-$0.03	$0.00
ROE (TTM)	-755.0%	-13745.0%
ROA (TTM)	-79248.0%	-9202.0%
ROIC (TTM)	-612.0%	-13717.0%
Financial Health
Cash	$177K	$761K
Debt	$1M	$6K
Net Cash/Debt	$-1M	$755K
Current Ratio (TTM)	0.03x	0.85x
Quick Ratio (TTM)	0.03x	0.60x
Debt/Equity (TTM)	0.20x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.80	2.20
52W Performance	-67.7%	-89.8%
YTD Performance	-68.2%	-69.1%
% from 52W High	-75.9%	-90.1%
% from 52W Low	14.5%	27.1%
Efficiency & Yields
Asset Turnover (TTM)	0.50x	0.09x
FCF Yield (TTM)	-34.2%	-16.3%
Earnings Yield (TTM)	-133.6%	-8.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BIXT research	View MTNB research